scispace - formally typeset
Journal ArticleDOI

Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium.

Reads0
Chats0
TLDR
There is no universal agreement on the definition of anaphylaxis or the criteria for diagnosis, so representatives from 16 different organizations or government bodies, including representatives from North America, Europe, and Australia, to continue working toward a universally accepted definition.
Abstract
There is no universal agreement on the definition of anaphylaxis or the criteria for diagnosis. In July 2005, the National Institute of Allergy and Infectious Disease and Food Allergy and Anaphylaxis Network convened a second meeting on anaphylaxis, which included representatives from 16 different organizations or government bodies, including representatives from North America, Europe, and Australia, to continue working toward a universally accepted definition of anaphylaxis, establish clinical criteria that would accurately identify cases of anaphylaxis with high precision, further review the evidence on the most appropriate management of anaphylaxis, and outline the research needs in this area.

read more

Citations
More filters
Journal ArticleDOI

Epidemiology of severe anaphylaxis: can we use population-based data to understand anaphylaxis?

TL;DR: An improved ability to accurately gather and analyse population-level anaphylaxis data in a harmonized fashion is required, so as to ultimately minimize risk and improve management.
Journal Article

Oral Immunotherapy in Children With IgE-Mediated Wheat Allergy: Outcome and Molecular Changes

TL;DR: The authors' wheat OIT protocol with wheat to treat IgE-mediated wheat-allergic children was safe, efficient, and rapid, and alpha-amylase inhibitors were recognized by all patients.
Journal ArticleDOI

Multinational experience with hypersensitivity drug reactions in Latin America

TL;DR: Nonsteroidal anti-inflammatory drugs and antibiotics were the drugs used in at least 75% of patients, and more than half the reactions were treated in the emergency department, whereas epinephrine was administered in fewer than 25% of Patients with anaphylaxis.
Journal ArticleDOI

Food allergy: Stakeholder perspectives on acceptable risk

TL;DR: The perspectives of the different stakeholders (allergic consumers, health professionals, public authorities and the food industry) on acceptable risk in food allergy are discussed and where these perspectives diverge and even conflict may help develop an approach to define what is acceptable.
Journal ArticleDOI

Diagnostic Value of Tryptase in Food Allergic Reactions: A Prospective Study of 160 Adult Peanut Challenges

TL;DR: Serum tryptase measurement is valuable in food allergic reactions, and correlates with symptom severity, and the optimal cutoff to identify a reaction as a 30% rise is demonstrated.
References
More filters
Journal ArticleDOI

Fatal and Near-Fatal Anaphylactic Reactions to Food in Children and Adolescents

TL;DR: Six children and adolescents who died of anaphylactic reactions to foods and seven others who nearly died and required intubation were identified and the failure to recognize the severity of these reactions and to administer epinephrine promptly increases the risk of a fatal outcome.
Journal ArticleDOI

Fatalities due to anaphylactic reactions to foods.

TL;DR: Fatal anaphylactic reactions to foods are continuing to occur, and better characterization might lead to better prevention, and peanuts and tree nuts accounted for more than 90% of the fatalities.
Journal ArticleDOI

Clinical features and severity grading of anaphylaxis

TL;DR: A simple grading system and definition of anaphylaxis has potential value for defining reaction severity in clinical practice and research settings and appears to be the major determinants of reaction severity.
Journal ArticleDOI

Advances in H1-Antihistamines

TL;DR: There are clinically relevant differences among H1-antihistamines in their pharmacology and safety profiles in allergic rhinoconjunctivitis and chronic urticaria.
Related Papers (5)